Impedimed Ltd logo

Impedimed Ltd

ASX:IPD (Australia)  
A$ 0.07 (-2.99%) Jun 13
At Loss
P/B:
2.60
Market Cap:
A$ 131.50M ($ 87.27M)
Enterprise V:
A$ 95.87M ($ 63.62M)
Volume:
5.84M
Avg Vol (2M):
1.48M
Also Trade In:
Volume:
5.84M
At Loss
Avg Vol (2M):
1.48M

Business Description

Description
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates most of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The Company recognizes revenue from stand alone sale of Legacy Devices and Consumables, Sale of SOZO Device and Software Subscription Services.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 28.99
Equity-to-Asset 0.87
Debt-to-Equity 0.03
Debt-to-EBITDA -0.06
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.46
Distress
Grey
Safe
Beneish M-Score -2.5
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 3.52
9-Day RSI 12.77
14-Day RSI 21.71
6-1 Month Momentum % -45.52
12-1 Month Momentum % -49.03

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7
Quick Ratio 6.85
Cash Ratio 6.23
Days Inventory 256.68
Days Sales Outstanding 92.27
Days Payable 618.12

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -26.3
Shareholder Yield % -20.55

Financials

ASX:IPD's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Impedimed Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 10.343
EPS (TTM) (A$) -0.01
Beta 2.17
Volatility % 65.71
14-Day RSI 21.71
14-Day ATR (A$) 0.003638
20-Day SMA (A$) 0.07765
12-1 Month Momentum % -49.03
52-Week Range (A$) 0.063 - 0.24
Shares Outstanding (Mil) 2,023.09

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Impedimed Ltd Filings

Filing Date Document Date Form
No Filing Data

Impedimed Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Impedimed Ltd Frequently Asked Questions

What is Impedimed Ltd(ASX:IPD)'s stock price today?
The current price of ASX:IPD is A$0.07. The 52 week high of ASX:IPD is A$0.24 and 52 week low is A$0.06.
When is next earnings date of Impedimed Ltd(ASX:IPD)?
The next earnings date of Impedimed Ltd(ASX:IPD) is .
Does Impedimed Ltd(ASX:IPD) pay dividends? If so, how much?
Impedimed Ltd(ASX:IPD) does not pay dividend.

Press Release

Subject Date
No Press Release